Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Pharmacokinetics
Published in: Clinical Pharmacokinetics 8/2023

23-06-2023 | Letter to the Editor

Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”

Authors: Meng Lv, Shengnan Zhang

Published in: Clinical Pharmacokinetics | Issue 8/2023

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Chung E, Sen J, Patel P, Seto W. Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review. Clin Pharmacokinet. 2021;60:985–1001.CrossRefPubMed
3.
Aljutayli A, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part I: in adults. Clin Pharmacokinet. 2020;59:671–98.CrossRefPubMed
4.
Aljutayli A, El-Haffaf I, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients. Clin Pharmacokinet. 2022;61:47–70.CrossRefPubMed
5.
6.
Li ZR, Wang CY, Zhu X, Jiao Z. Population pharmacokinetics of levetiracetam: a systematic review. Clin Pharmacokinet. 2021;60:305–18.CrossRefPubMed
7.
Zamir A, Hussain I, Ur Rehman A, Ashraf W, Imran I, Saeed H, et al. Clinical pharmacokinetics of metoprolol: a systematic review. Clin Pharmacokinet. 2022;61:1095–114.CrossRefPubMed
8.
Qin Y, Zhang LL, Ye YR. Parametric population pharmacokinetics of linezolid: a systematic review. Br J Clin Pharmacol. 2022;88:4043–66.CrossRefPubMed
9.
Muda MR, Harun SN, Syed Sulaiman SA, Sheikh Ghadzi SM. Population pharmacokinetics analyses of rifampicin in adult and children populations: a systematic review. Br J Clin Pharmacol. 2022;88:3132–52.CrossRefPubMed
10.
Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH. Fundamentals of population pharmacokinetic modelling: modelling and software. Clin Pharmacokinet. 2012;51:515–25.CrossRefPubMed
11.
Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z. Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations. Clin Pharmacokinet. 2021;60:53–68.CrossRefPubMed
12.
Hughes JH, Tong DMH, Faldasz JD, Frymoyer A, Keizer RJ. Evaluation of neonatal and paediatric vancomycin pharmacokinetic models and the impact of maturation and serum creatinine covariates in a large multicentre data set. Clin Pharmacokinet. 2023;62:67–76.CrossRefPubMed
13.
Jiao Z. Basic population pharmacokinetic and pharmacodynamic analysis. 3rd ed. Beijing: Science Press; 2020.
14.
Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, et al. Reporting guidelines for clinical pharmacokinetic studies: the ClinPK statement. Clin Pharmacokinet. 2015;54:783–95.CrossRefPubMed
Metadata
Title
Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”
Authors
Meng Lv
Shengnan Zhang
Publication date
23-06-2023
Publisher
Springer International Publishing
Published in
Clinical Pharmacokinetics / Issue 8/2023
Print ISSN: 0312-5963
Electronic ISSN: 1179-1926
DOI
https://doi.org/10.1007/s40262-023-01271-1

Other articles of this Issue 8/2023

Clinical Pharmacokinetics 8/2023 Go to the issue

Original Research Article

A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women

Original Research Article

Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs

Original Research Article

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients

Original Research Article

Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates

Original Research Article

Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment

Review Article

Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor